Survey for Melanoma During COVID-19
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how the COVID-19 pandemic has affected the overall well-being and quality of life in people with melanoma, a type of skin cancer. Researchers seek to learn about the psychological stress related to COVID-19, changes in healthcare, financial impacts, and social interactions. Participants will complete a short, 10-minute survey about these experiences. The trial seeks melanoma patients who have already agreed to share their lifestyle data in a previous study and can be contacted online. As an unphased trial, this study offers participants the opportunity to contribute valuable insights into the broader impacts of the pandemic on the lives of melanoma patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on a questionnaire about experiences during the COVID-19 pandemic, so it's unlikely that medication changes are required.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on understanding the well-being and quality of life of melanoma patients during the COVID-19 pandemic through survey administration. Unlike traditional treatments that center on directly attacking melanoma, this approach seeks to gather valuable insights into how patients are coping with the additional stress and challenges posed by the pandemic. By collecting this information, researchers aim to identify specific needs and areas for support, which could lead to improved patient care strategies and mental health interventions tailored to this unique situation.
Who Is on the Research Team?
Lorenzo Cohen
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey Administration
Participants complete a 10-minute survey assessing experiences during the COVID-19 pandemic, psychological distress, and health-related quality of life
Follow-up
Participants are monitored for any changes in psychological distress and health-related quality of life after survey completion
What Are the Treatments Tested in This Trial?
Interventions
- Survey Administration
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients complete a survey over 10 minutes.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.